Showing 121 - 140 results of 757 for search '"relapse prevention"', query time: 0.52s Refine Results
  1. 121

    Cognitive Processing Therapy or Relapse Prevention for comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A randomized clinical trial. by Tracy L Simpson, Debra L Kaysen, Charles B Fleming, Isaac C Rhew, Anna E Jaffe, Sruti Desai, Denise A Hien, Lucy Berliner, Dennis Donovan, Patricia A Resick

    Published 2022-01-01
    “…<h4>Objective</h4>To compare a Posttraumatic Stress Disorder (PTSD) treatment (Cognitive Processing Therapy; CPT), an Alcohol Use Disorder (AUD) treatment (Relapse Prevention; RP), and assessment-only (AO) for those meeting diagnostic criteria for both PTSD and AUD.…”
    Get full text
    Article
  2. 122

    How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding by Michael P. Hengartner

    Published 2020-05-01
    “…The aim of this article is to discuss the validity of relapse prevention trials and the issue of withdrawal confounding in these trials. …”
    Get full text
    Article
  3. 123

    Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1 by Xiangyu Lu, Le Kuai, Fang Huang, Jingsi Jiang, Jiankun Song, Yiqiong Liu, Si Chen, Lijie Mao, Wei Peng, Ying Luo, Yongyong Li, Haiqing Dong, Bin Li, Jianlin Shi

    Published 2023-10-01
    “…Here we show that biomimetic iron single-atom catalysts (FeN4O2-SACs) with broad-spectrum ROS scavenging capability can be used for psoriasis treatment and relapse prevention via related gene restoration. FeN4O2-SACs demonstrate attractive multiple enzyme-mimicking activities based on atomically dispersed Fe active structures, which are analogous to those of natural antioxidant enzymes, iron superoxide dismutase, human erythrocyte catalase, and ascorbate peroxidase. …”
    Get full text
    Article
  4. 124

    Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: A systematic review and economic evaluation by Adi, Y, Juarez-Garcia, A, Wang, D, Jowett, S, Frew, E, Day, E, Bayliss, S, Roberts, T, Burls, A

    Published 2007
    “…Objectives: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse prevention in detoxified formerly opioid-dependent individuals compared with any strategy that does not use naltrexone, including treatment with placebo, other pharmacological treatments, psychosocial interventions or no treatment. …”
    Journal article
  5. 125

    Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation by Adi, Y, Juarez-Garcia, A, Wang, D, Jowett, S, Frew, E, Day, E, Bayliss, S, Roberts, T, Burls, A

    Published 2007
    “…To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse prevention in detoxified formerly opioid-dependent individuals compared with any strategy that does not use naltrexone, including treatment with placebo, other pharmacological treatments, psychosocial interventions or no treatment. …”
    Journal article
  6. 126

    Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. by Adi, Y, Juarez-Garcia, A, Wang, D, Jowett, S, Frew, E, Day, E, Bayliss, S, Roberts, T, Burls, A

    Published 2007
    “…OBJECTIVES: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse prevention in detoxified formerly opioid-dependent individuals compared with any strategy that does not use naltrexone, including treatment with placebo, other pharmacological treatments, psychosocial interventions or no treatment. …”
    Journal article
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131

    Cognitive remediation following electroconvulsive therapy in patients with treatment resistant depression: randomized controlled trail of an intervention for relapse prevention – study protocol by Nele Van de Velde, Mitchel Kappen, Ernst H. W. Koster, Kristof Hoorelbeke, Hannelore Tandt, Pieter Verslype, Chris Baeken, Rudi De Raedt, Gilbert Lemmens, Marie-Anne Vanderhasselt

    Published 2020-09-01
    “…Unfortunately, longitudinal data show low sustained response rates with 6-month relapse rates as high as 50% using existing relapse prevention strategies. Cognitive side effects of ECT, even though transient, might trigger mechanisms that increase relapse in patients who initially responded to ECT. …”
    Get full text
    Article
  12. 132

    Can the Addition of Maintenance Electroconvulsive Therapy to Pharmacotherapy Improve Relapse Prevention in Severe Major Depressive Disorder?... by Erika Martínez-Amorós, Narcís Cardoner, Verònica Gálvez, Aida de Arriba-Arnau, Virginia Soria, Diego J. Palao, José M. Menchón, Mikel Urretavizcaya

    Published 2021-10-01
    “…Few systematic evaluations have been performed of the efficacy of electroconvulsive therapy (ECT) as a relapse prevention strategy in major depressive disorder (MDD). …”
    Get full text
    Article
  13. 133
  14. 134
  15. 135

    Usage Intensity of a Relapse Prevention Program and Its Relation to Symptom Severity in Remitted Patients With Anxiety and Depression: Pre-Post Study by Esther Krijnen-de Bruin, Anna DT Muntingh, Evelien M Bourguignon, Adriaan Hoogendoorn, Otto R Maarsingh, Anton JLM van Balkom, Neeltje M Batelaan, Annemieke van Straten, Berno van Meijel

    Published 2022-03-01
    “… BackgroundGiven that relapse is common in patients in remission from anxiety and depressive disorders, relapse prevention is needed in the maintenance phase. Although existing psychological relapse prevention interventions have proven to be effective, they are not explicitly based on patients’ preferences. …”
    Get full text
    Article
  16. 136
  17. 137
  18. 138

    Relapse prevention group therapy via video-conferencing for substance use disorder: protocol for a multicentre randomised controlled trial in Indonesia by Tomohiro Shinozaki, Ryota Sakamoto, Toshihiko Matsumoto, Chika Yamada, Kristiana Siste, Enjeline Hanafi, Youdiil Ophinni, Evania Beatrice, Vania Rafelia, Peter Alison, Albert Limawan

    Published 2021-09-01
    “…The intervention arm will participate in a relapse prevention programme called the Indonesia Drug Addiction Relapse Prevention Programme (Indo-DARPP), a newly developed 12-week module based on CBT and motivational interviewing constructed in the Indonesian context. …”
    Get full text
    Article
  19. 139

    Personalised app-based relapse prevention of depressive and anxiety disorders in remitted adolescents and young adults: a protocol of the StayFine RCT by Claudi Bockting, Suzanne J Robberegt, Bas E A M Kooiman, Casper J Albers, Maaike H Nauta, Yvonne Stikkelbroek

    Published 2022-12-01
    “…Introduction Youth in remission of depression or anxiety have high risks of relapse. Relapse prevention interventions may prevent chronicity. …”
    Get full text
    Article
  20. 140

    Comparing Effectiveness of Mindfulness-Based Relapse Prevention with Treatment as Usual on Impulsivity and Relapse for Methadone-Treated Patients: A Randomized Clinical Trial by Mehdi Yaghubi, Fatemeh Zargar, Hossein Akbari

    Published 2017-11-01
    “…These findings suggest that MBRP is useful for opioid-dependent individuals with high-level impulsivity, and relapse prevention.…”
    Get full text
    Article